Lupin to co-market Novartis’ asthma drug in India
BS B2B Bureau | Mumbai April 12, 2016 Last Updated at 10:27 IST
Novartis Healthcare will continue to market Sequadra (indacaterol/glycopyrronium inhaler), while Lupin will promote the inhaler under the brand name Loftair in India
read original article at
/////inhaler, Novartis Healthcare, Sequadra, indacaterol, glycopyrronium inhaler, Lupin, inhaler, brand name, Loftair, India
